Cargando…
Snake Venom-specific Phospholipase A2: A Diagnostic Marker for the Management of Snakebite Cases
BACKGROUND: Snakebites are a common cause of morbidity and mortality, especially in tropical countries. Snakebites in any community are managed based on the clinical features and intravenous administration of antisnake venom (ASV). The administration of ASV is either deficient or given in excess bas...
Autores principales: | Kaulgud, Ram S, Hasan, Tousif, Vanti, Gulamnabi L, Veeresh, S, Uppar, Amruta P, Kurjogi, Mahantesh M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886021/ https://www.ncbi.nlm.nih.gov/pubmed/36755629 http://dx.doi.org/10.5005/jp-journals-10071-24362 |
Ejemplares similares
-
Prevalence of hypertension and its associated risk factors in Dharwad population: A cross-sectional study
por: Kurjogi, Mahantesh M., et al.
Publicado: (2021) -
Diversity of Phospholipases A(2) from Bothrops atrox Snake Venom: Adaptive Advantages for Snakes Compromising Treatments for Snakebite Patients
por: Sousa, Leijiane F., et al.
Publicado: (2022) -
Children and Snakebite: Snake Venom Effects on Adult and Paediatric Plasma
por: Zdenek, Christina N., et al.
Publicado: (2023) -
Is anti‐snake venom required for all snakebites: A case report
por: Dorji, Thinley
Publicado: (2019) -
Serious Adverse Reactions to Anti-snake Venom in Children with Snake Envenomation: An Underappreciated Contributor to Snakebite Mortality?
por: Hooda, Rashmi, et al.
Publicado: (2021)